FreedomFest 2026

An investment today can help us all as we age by maintaining muscle mass, which is crucial for balance and reducing the risk of falls. Let's strive for longer health spans and lifespans together.

I am an experienced pharmaceutical executive with a distinguished career spanning over 30 years in the industry. I am currently the CEO of Sarcomatrix Therapeutics, a pre-clinical biotechnology company focused on developing innovative treatments for muscle-wasting diseases, starting with muscular dystrophy.

I've held several senior leadership positions in various pharmaceutical companies, including Amgen, Gilead, and Alexion. I have extensive experience in fundraising, drug development, and commercialization, and I have led successful global product launches for multiple blockbuster drugs.

I also serve as an advisor and consultant to several pharmaceutical companies, providing strategic guidance on clinical development and commercialization. My passion for advancing healthcare through innovative solutions and my commitment to improving patient outcomes make me a respected leader in the field.

We are seeking a syndicate lead to leverage support from Governor Lombardo and his GOED Team's Battle Born Venture Fund. We have a letter of commitment in hand.

By investing today, we can greatly enhance our future well-being. Maintaining muscle mass is crucial for ensuring balance and minimizing the risk of falls as we grow older. Additionally, our support can drive the development of treatments for muscular dystrophies and other muscle-wasting conditions. Together, we can aim for extended health spans and lifespans, paving the way for a healthier and more vibrant future.

Sincerely,
David